Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US
在美国以社区为主的环境中,维奈托克和去甲基化药物作为新诊断急性髓系白血病患者的一线治疗
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyac135
Vachhani, Pankit; Flahavan, Evelyn M; Xu, Tao; Ma, Esprit; Montez, Melissa; Gershon, Anda; Onishi, Maika; Jin, Huan; Ku, Grace; Flores, Brannon; Bui, Cat N; Abbas, Jonathan A; Donnellan, William